IonQ, Inc. — Q1 2022 Form 10-Q Summary
Business context and reporting period
IonQ develops trapped-ion quantum computers and sells access through its quantum-computing-as-a-service platform and related consulting. This unaudited report covers the three months ended March 31, 2022, compared with Q1 2021. IonQ describes itself as an early-stage business, currently offering a 20 algorithmic-qubit system while developing more capable systems.
Financial performance and liquidity
- Revenue: $1.95 million, up 1,462% from $0.13 million. Management attributed the increase mainly to three new service contracts.
- Costs and losses: Operating expenses were $20.24 million, versus $7.46 million. Operating loss widened to $18.28 million from $7.34 million. Net loss was $4.23 million, compared with $7.34 million; the 2022 result included a $13.45 million non-cash gain from a change in fair value of warrant liabilities. Loss per share was $0.02 versus $0.06.
- Margins: Cost of revenue, excluding depreciation and amortization, was $0.57 million. The filing does not present a standalone gross-margin measure; this cost figure excludes depreciation and amortization.
- Cash flow: Cash used in operating activities was $8.32 million, compared with $3.90 million. Investing activities used $304.10 million, largely reflecting $311.24 million of purchases of available-for-sale securities, partly offset by maturities. Financing activities provided $0.15 million.
- Liquidity: At quarter-end, cash and cash equivalents were $86.75 million; short- and long-term investments totaled $499.62 million. Current assets were $422.30 million and current liabilities $11.39 million. Management said cash, cash equivalents and investments should fund working capital and capital expenditures for at least the next 12 months, subject to changing conditions.
- Debt and obligations: The balance sheet reports no borrowings. Total liabilities were $37.67 million, including $20.51 million of warrant liabilities. Operating lease obligations totaled $6.8 million, with $0.7 million due within 12 months. Accumulated deficit was $150.02 million.
Changes versus Q1 2021
Revenue grew from a small base, but research and development, sales and marketing, general and administrative, and depreciation and amortization expenses all increased. Management cited higher headcount and compensation, increased research materials and equipment costs, public-company expenses, and higher director and officer insurance costs. Stock-based compensation expense, net of amounts capitalized, rose to $6.67 million from $1.43 million. Cash and investments shifted toward securities during the quarter; total cash, cash equivalents and investments were $586.37 million at March 31, compared with $602.58 million at year-end 2021. Unrealized losses on available-for-sale securities contributed $4.54 million to other comprehensive loss.
Outlook, commentary, risks and unusual items
- IonQ expects significant losses and higher operating expenses for the foreseeable future, and says significant production of quantum computers is not expected before 2025 at the earliest. The filing gives no specific revenue or earnings guidance.
- Management highlighted the IonQ Aria system’s 20 algorithmic qubits, commercial and research collaborations, and the planned IonQ Forte system. Forte was expected to have select access in the second half of 2022 and broader customer access in 2023; these are forward-looking expectations, not reported results.
- Remaining performance obligations on non-cancelable contracts were approximately $21.3 million, with $7.1 million expected to be recognized during the remaining nine months of 2022. Two customers accounted for a majority of Q1 2022 revenue. A related-party arrangement with the University of Maryland contributed $0.99 million of Q1 revenue.
- Principal risks include failure to scale quantum systems or achieve broad quantum advantage, intense competition, reliance on cloud providers and specialized suppliers, and ongoing funding needs. COVID-19 and geopolitical events could disrupt operations or supply chains.
- Control weakness: Management concluded disclosure controls were not effective as of March 31, 2022, due to an unremediated material weakness in the financial-statement close process, including limited accounting-system functionality and processes not fully formalized. Remediation work was underway; management said the weakness would not be considered remediated until controls were implemented and tested as effective.
- Other unusual items: The filing describes a pending lawsuit involving dMY-related parties and states management did not expect its resolution to materially adversely affect IonQ. It also discloses a May 3, 2022 short-seller report containing allegations and warns that related inquiries or litigation could divert resources. The filing does not establish the accuracy of those allegations.
Important facts for investors to verify
- Whether revenue growth continues, how concentrated revenue remains among major customers, and how much of reported revenue converts to cash.
- Progress against technical and commercialization milestones, including IonQ Forte access plans and the longer-term path to scalable systems.
- Operating cash burn, investment liquidity and fair-value exposure, and whether management’s stated 12-month liquidity outlook remains valid.
- Whether the material weakness is fully remediated and disclosure controls become effective.
- Developments in the short-seller allegations, related inquiries or litigation, the dMY-related lawsuit, and related-party university arrangements.